Health
Medical
Pharmaceutical

OptiNose

$6.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.17%) As of 12:51 PM EDT today
-$0.01 (-0.17%) Today

Why Robinhood?

You can buy or sell OptiNose and other stocks, options, ETFs, and crypto commission-free!

About OPTN

OptiNose, Inc. Common Stock, also called OptiNose, is a pharmaceutical company, which engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Read More Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in May 2010 and is headquartered in Yardley, PA.

Employees
102
Headquarters
Yardley, Pennsylvania
Founded
2010
Market Cap
250.06M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
319.32K
High Today
$6.16
Low Today
$5.84
Open Price
$6.04
Volume
96.91K
52 Week High
$24.55
52 Week Low
$5.66

Collections

Health
Medical
Pharmaceutical
2017 IPO
US
North America

OPTN Earnings

-$0.82
-$0.71
-$0.61
-$0.50
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 13, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.